Press release
Naltrexone Market Size is Anticipated to Reach USD 30.8 billion, Garnering a 3.6 % CAGR by 2034: TMR Report
Naltrexone
Naltrexone Market (날트렉손 시장) is expected to grow at a CAGR of 3.6% from 2024 to 2034 and reach US$ 30.8 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=64916
Overview of Naltrexone Market
The global naltrexone market is experiencing steady growth, driven by increasing awareness of substance use disorders, expanding treatment options, and rising government initiatives to combat addiction. The market includes oral naltrexone tablets, extended-release injectable formulations, and combination therapies involving naltrexone. Key segments of the market are based on formulation type, application, distribution channel, and geographical regions.
Global Market Key Players
Taj Pharmaceuticals
IVAX Paper Chemicals
Faran Shimi
AdooQ Bioscience LLC
Sun Pharmaceutical Industries Ltd.
Sanofi S.A.
Freedom Pharmaceuticals
Ascent Scientific
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals
Recent Developments in Naltrexone Market
Recent advancements and trends in the naltrexone market include:
Extended-Release Formulations: Development and approval of long-acting injectable formulations, such as Vivitrol, providing sustained release and improved compliance.
Combination Therapies: Research into and use of combination therapies involving naltrexone and other medications, such as buprenorphine, to enhance treatment efficacy.
Digital Health Integration: Incorporation of digital health tools and telemedicine to support adherence and monitoring in naltrexone-based treatment programs.
Policy Support: Increased support from government policies and funding initiatives aimed at expanding access to addiction treatment services.
Patient-Centric Approaches: Focus on personalized treatment plans and patient education to improve outcomes in naltrexone therapy.
Drivers of Market Growth
Several factors contribute to the growth of the naltrexone market:
Rising Prevalence of Substance Use Disorders: Increasing rates of alcohol and opioid dependence globally drive the demand for effective treatment options like naltrexone.
Government Initiatives: Government initiatives and funding to combat the opioid crisis and substance abuse enhance the availability and adoption of naltrexone.
Advancements in Formulations: Development of new and improved naltrexone formulations, such as extended-release injectables, improve patient adherence and treatment outcomes.
Growing Awareness: Rising awareness among healthcare providers and patients about the benefits of naltrexone in managing addiction.
Supportive Regulations: Supportive regulatory frameworks and expedited approvals for addiction treatments facilitate market growth.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=64916
Conclusion
The naltrexone market is poised for significant growth, driven by rising awareness of substance use disorders, government initiatives, and advancements in treatment formulations. Innovations in extended-release formulations, combination therapies, and digital health integration are enhancing the effectiveness and accessibility of naltrexone treatment.
Market Segmentation
Type
25 mg
50 mg
Application
Opioid Independence
Alcohol Independence
End-user
Hospitals & Clinics
Rehabilitation Centers
Wellness Centers
Others (Research and Academic Institutes, etc.)
By Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=64916<ype=S
More Trending Report by Transparency Market Research:
Sterile Medical Packaging Market (滅菌医療包装市場): https://www.globenewswire.com/news-release/2024/07/05/2909046/0/en/Sterile-Medical-Packaging-Market-to-Cross-USD-15-2-Billion-by-2031-Driven-by-Significant-Growth-in-the-Pharmaceutical-Industry-at-a-CAGR-of-4-7-TMR.html
Blood Pressure Cuffs Market (Marché des brassards de tension artérielle): https://www.prnewswire.com/news-releases/rising-hypertension-rates-boost-blood-pressure-cuffs-market-revenue-projected-to-reach-usd-1-0-billion-by-2031-at-6-5-cagr-transparency-market-research-inc-302190730.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Naltrexone Market Size is Anticipated to Reach USD 30.8 billion, Garnering a 3.6 % CAGR by 2034: TMR Report here
News-ID: 3572536 • Views: …
More Releases from Transparency Market Research
Global Coal Market Outlook 2036: Industry to Reach US$ 2,558.8 Billion by 2036 D …
The global coal market was valued at US$ 1,595.1 Bn in 2025 and is projected to reach US$ 2,558.8 Bn by 2036, expanding at a CAGR of 4.4% from 2026 to 2036. The industry continues to remain a cornerstone of global energy systems, particularly in emerging economies where coal-fired power generation supports industrialization and infrastructure growth.
Asia Pacific dominated the global coal market in 2025, accounting for 83.0% of total revenue…
Metalworking Fluids Market Expanding at 3.7% CAGR Through 2036 - By Type / By Ap …
The global metalworking fluids market was valued at US$ 11.8 Bn in 2025 and is projected to reach US$ 17.6 Bn by 2036, expanding at a steady CAGR of 3.7% during the forecast period from 2026 to 2036. The market's moderate yet stable growth trajectory reflects its strong integration into essential industrial operations across automotive, aerospace, construction, marine, medical, and heavy engineering sectors.
Get a concise overview of key insights from…
Bio-based Epoxy Resin Market to Reach US$ 11.5 Billion by 2036 Amid Sustainabili …
The global bio-based epoxy resin market is entering a transformative growth phase as industries shift toward sustainable and low-carbon material solutions. Valued at US$ 6.4 billion in 2025, the market is projected to reach US$ 11.5 billion by 2036, expanding at a CAGR of 5.5% from 2026 to 2036. Increasing regulatory pressure, evolving sustainability mandates, and the growing adoption of renewable raw materials are accelerating demand across multiple end-use industries.
Bio-based…
Plant Growth Regulators Market to Reach US$ 11.97 Billion by 2036, Driven by Ris …
The global plant growth regulators market was valued at US$ 7,569.9 Mn in 2025 and is projected to reach US$ 11,971.1 Mn by 2036, expanding at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2036. Market growth is primarily driven by rising pressure to improve agricultural productivity and the rapid expansion of high-value crops and protected cultivation systems worldwide.
Access key findings and insights from our Report in…
More Releases for Naltrexone
Belgium Naltrexone Market to Garner Brimming Revenues by 2024
Naltrexone Market: Introduction
• Naltrexone is an opioid blocker that acts by preventing the symptoms of opioids from both inside and outside the body. Naltrexone is a drug that is commonly used to treat alcohol or opioid use disorder by reducing cravings and symptoms of euphoria associated with the disorder. A person who is addicted to opioids should not be given naltrexone before detoxification. Naltrexone is administered orally or by injection into…
Naltrexone HCL market global outlook and forecast 2021 -2027| Sanofi ,Noramco
The report gives a complete investigation of the Naltrexone HCL industry and key market improvements. The exploration record comprises of past and figure showcase data, prerequisite, territories of use, value strategies, and friends portions of the main organizations by topographical district. The Naltrexone HCL report separates the market size, by volume and worth, depending upon the kind of utilization and area. With everything taken into account, the keyword…
Naltrexone HCL Market to Obtain Awesome Hike in Revenues
Global Naltrexone HCL Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, “Naltrexone HCL Market by Type (Medical Grade and Others) and Application…
Naltrexone HCL Market: Competitive Dynamics & Global Outlook 2024
Market Research Report Store offers a latest published report on Naltrexone HCL Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Naltrexone HCL market will register a 0.8% CAGR in terms of revenue, the global market size will reach US$ 20 million by 2024, from US$ 20 million in 2019. In…
Naltrexone HCL Market : Industry to Witness a Rise by year 2023
The opioid antagonist Natrexon HCL is a synthetic homolog of oxymorphone without an opioid agonist. It reversibly reduces or completely blocks the subjective effects of intravenous opioids. This medication is usually given orally to treat alcohol dependence. Naltrexone HCL is needed in the context of increased alcohol dependence as alcohol consumption worldwide increases.
Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/3660
The market is predominantly alcohol-dependent worldwide. According to the National…
Thebaine Market- by Applications Oxymorphone, Nalbuphine, Naltrexone
Launch of new campaigns to promote drug abuse treatment is expected to be a major driver for growth of global thebaine market. For instance, in 2018, Trump administration i.e. White House Administration launched a multi-million dollar opioid awareness campaign for young adults. This campaign aims at curbing addition of opioid among young population. This campaign also spreads awareness by sharing true life stories of drug addicts to educate teens as…
